Cancer News and Research

Latest Cancer News and Research

Genetic analysis revises treatment recommendations related to thyroid cancer

Cleveland Clinic researchers have discovered three genes that increase the risk of thyroid cancer, which is has the largest incidence increase in cancers among both men and women.

23 Dec 2011

Jenna Bush Hager reports on family trip to Africa to visit health programs on NBC's Today Show

In this video clip from NBC's Today show, contributing correspondent Jenna Bush Hager reports on a recent family trip to Africa to visit PEPFAR-funded programs and to announce a new initiative by the George W. Bush Institute to fight cervical cancer.

23 Dec 2011

Tyrosine kinases play greater role in mitochondria than previously recognized

Cancer cells tend to take up more glucose than healthy cells, and researchers are increasingly interested in exploiting this tendency with drugs that target cancer cells' altered metabolism.

From Cell Signaling Technology 23 Dec 2011

Research roundup: Unraveling why elderly men are tested for prostate cancer; Difficulty paying medical bills

Medical Center Characteristics Associated With PSA Screenings In Elderly Veterans With Limited Life Expectancy -- Medical guidelines recommend against prostate-specific antigen (PSA) screenings for prostate cancer in men with limited life expectancy, but studies have shown that many elderly men still get the test.

23 Dec 2011

Acceleron Pharma raises $30 million through private financing

Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases, today announced it raised a $30M private financing.

23 Dec 2011

Biosensors capable of detecting lung cancer in exhaled breath

Tecnalia, through the Interreg project Medisen, is contributing to develop biosensors capable of detecting the presence of tumour markers of lung cancer in exhaled breath.

23 Dec 2011

Racial disparities in stage-specific colorectal cancer mortality rates

A new study finds that while colorectal cancer mortality rates dropped in the most recent two decades for every stage in both African Americans and whites, the decreases were smaller for African Americans, particularly for distant stage disease.

23 Dec 2011

Anti-cancer drugs may also fight antibiotic resistance

Drugs used to overcome cancer may also combat antibiotic resistance, finds a new study led by Gerry Wright, scientific director of the Michael G. DeGroote Institute for Infectious Disease Research at McMaster University.

23 Dec 2011

Study finds limited pain education at North American medical schools

Even though pain is by far the leading reason people seek medical care, pain education at North American medical schools is limited, variable and often fragmentary, according to a Johns Hopkins University study published in The Journal of Pain.

23 Dec 2011

UCF scientists pioneer new source of stem cell generation

A process that prompts a single gene to generate millions of supercharged stem cells, which can then turn into any kind of cell a body needs to repair itself, has been patented at the University of Central Florida.

23 Dec 2011

Researchers reveal what cells respond to anesthesia in C. elegans

Physicians use inhalation anesthetics in a way that is incredibly safe for patients, but very little is known about the intricacies of how these drugs actually work in children and adults. Now, researchers have uncovered what cells respond to anesthesia in an organism known as the C. elegans, according to a new study from the Seattle Children's Research Institute. C. elegans is a transparent roundworm used often in research.

23 Dec 2011

Researchers successfully treat severe congenital disorder in mouse model

Using a mouse model, Heidelberg University Hospital researchers have for the first time successfully treated a severe congenital disorder in which sugar metabolism is disturbed.

23 Dec 2011

Scientists discover how DNA mismatch repair proteins work

In eukaryotes - the group of organisms that include humans - a key to survival is the ability of certain proteins to quickly and accurately repair genetic errors that occur when DNA is replicated to make new cells.

23 Dec 2011

Researchers present results from 31 major studies of blood-related cancers at ASH 2011 meeting

Researchers from the John Theurer Cancer Center at Hackensack University Medical Center, one of the nation's top 50 best hospitals for cancer, presented results from 31 major studies of blood-related cancers - leukemia, lymphoma and multiple myeloma -- during the American Society of Hematology (ASH) Annual Meeting, December 10-13, 2011 in San Diego.

23 Dec 2011

Scientists discover mechanism by which TNFα stimulates tumor formation

An inflammation-promoting protein triggers deactivation of a tumor-suppressor that usually blocks cancer formation via the NOTCH signaling pathway, a team of researchers led by scientists at The University of Texas MD Anderson Cancer Center reports today in Molecular Cell.

23 Dec 2011

Researchers identify previously unknown gene fusion event in lung cancer

Smoking is a well-known risk factor for lung cancer, but nearly 25% of all lung cancer patients have never smoked. In a study published online today in Genome Research, researchers have identified a previously unknown gene fusion event that could explain a significant proportion of lung cancer cases in never-smokers, and might serve as a target for new therapies.

23 Dec 2011

Momenta, Baxter partner to develop and commercialize biosimilars

Baxter International Inc. and Momenta Pharmaceuticals, Inc. today announced that they have entered into a global collaboration to develop and commercialize follow-on biologic products, also known as biosimilars.

From Baxter International Inc. 23 Dec 2011

ECMC network receives £35M grants for cancer medicine research

The Experimental Cancer Medicine Centres (ECMC) network, which runs UK clinical studies of the newest cancer treatments, has been awarded a second wave of £35M funding for the next five years.

23 Dec 2011

ThromboGenics submits ocriplasmin BLA with FDA to treat symptomatic VMA

ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that it has submitted a Biologics License Application (BLA) with the U.S. Food and Drug Administration (FDA) for ocriplasmin Intravitreal Injection, 2.5 mg/mL, for the treatment of symptomatic VMA including macular hole.

23 Dec 2011

D12-PGJ3 compound can cure leukemia

A compound produced from fish oil that appears to target leukemia stem cells could lead to a cure for the disease, according to Penn State researchers. The compound -- delta-12-protaglandin J3, or D12-PGJ3 -- targeted and killed the stem cells of chronic myelogenous leukemia, or CML, in mice, said Sandeep Prabhu, associate professor of immunology and molecular toxicology in the Department of Veterinary and Medical Sciences.

23 Dec 2011